ICON Public Limited Company (ICLR)

IE — Healthcare Sector
Peers: EXAS  GH  MEDP  QGEN  UHS  RVTY  COO  EHC  NBIX  SOLV 

Automate Your Wheel Strategy on ICLR

With Tiblio's Option Bot, you can configure your own wheel strategy including ICLR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ICLR
  • Rev/Share 104.7206
  • Book/Share 120.6465
  • PB 0.8675
  • Debt/Equity 0.3826
  • CurrentRatio 1.0588
  • ROIC 0.0685

 

  • MktCap 7991830483.0
  • FreeCF/Share 12.87
  • PFCF 8.0255
  • PE 13.5083
  • Debt/Assets 0.2164
  • DivYield 0
  • ROE 0.0632

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 2
  • DCF Score 5
  • P/B Score 4
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade ICLR Jefferies Hold Buy -- $135 Feb. 23, 2026
Upgrade ICLR TD Cowen Hold Buy -- $120 Feb. 18, 2026
Downgrade ICLR Rothschild & Co Redburn Buy Neutral -- $100 Feb. 17, 2026
Downgrade ICLR BofA Securities Neutral Underperform -- $75 Feb. 12, 2026
Downgrade ICLR Leerink Partners Outperform Market Perform -- $105 Feb. 12, 2026
Downgrade ICLR Truist Buy Hold -- $222 Jan. 8, 2026
Downgrade ICLR BofA Securities Buy Neutral -- $195 Dec. 15, 2025
Initiation ICLR BMO Capital Markets -- Market Perform -- $175 Nov. 13, 2025
Downgrade ICLR Jefferies Buy Hold -- $175 Sept. 9, 2025
Upgrade ICLR Rothschild & Co Redburn Neutral Buy -- $236 Sept. 3, 2025

News

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of ICON PLC (ICLR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
ICLR
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral

ATLANTA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against ICON PLC (“ICON” or the “Company”) (NASDAQ: ICLR). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose adverse facts about the Company's business, operations, and financial condition, including allegations that ICON was suffering from a material loss of business due to customer cost reduction measures and other widespread funding limitations impacting the Company's client base.

Read More
image for news INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of ICON PLC (ICLR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
ICLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ICLR
Published: February 11, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ICON PLC ("ICON" or "the Company") (NASDAQ:ICLR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ICON securities between July 27, 2023 and October 23, 2024, both dates inclusive (the "Class Period").

Read More
image for news ICLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ICON INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead the ICON Class Action Lawsuit
ICLR
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), the ICON class action lawsuit charges ICON and certain of ICON's top executive officers with violations of the Securities Exchange Act of 1934.

Read More
image for news ICON INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ICON PLC and Announces Opportunity for Investors with Substantial Losses to Lead the ICON Class Action Lawsuit

About ICON Public Limited Company (ICLR)

  • IPO Date 1998-05-15
  • Website https://www.iconplc.com
  • Industry Medical - Diagnostics & Research
  • CEO Barry Balfe
  • Employees 41250

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.